(b) The purpose of the technical advisory committee is to:

(1) Review requests for information from the Program under § 21-2A-06(b)(3), (4), (5), (6), (8), or (9) of this subtitle; and

(2) Provide clinical guidance and interpretation to the Program regarding indications of possible misuse or abuse of a monitored prescription drug or a possible violation of law or a possible breach of professional standards by a prescriber or a dispenser under § 21-2A-06(c) and (d) of this subtitle.

(c) The technical advisory committee consists of members appointed by the Secretary, including:

(1) A board certified anesthesiologist licensed and practicing in the State, nominated by the Maryland Society of Anesthesiologists;

(2) A certified addiction medicine specialist licensed and practicing in the State, nominated by the Maryland Society for Addiction Medicine;

(3) A pharmacist licensed and practicing in the State;

(4) A medical professional, licensed and practicing in the State, who is treating cancer patients;

(5) A board certified physician specializing in the treatment of patients with pain, licensed and practicing in the State, nominated by the Maryland Society of Physical Medicine and Rehabilitation;

(6) Two medical professionals, licensed and practicing in the State with expertise or experience in providing care for patients with substance-related or mental health disorders;

(7) A dentist licensed and practicing in the State; and

(8) A medical professional licensed and practicing in the State in the field of internal medicine or family practice.